ARF1_HUMAN - dbPTM
ARF1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ARF1_HUMAN
UniProt AC P84077
Protein Name ADP-ribosylation factor 1
Gene Name ARF1
Organism Homo sapiens (Human).
Sequence Length 181
Subcellular Localization Golgi apparatus . Cytoplasm, perinuclear region . Cell junction, synapse, synaptosome. Cell junction, synapse, postsynaptic cell membrane, postsynaptic density. Membrane
Lipid-anchor .
Protein Description GTP-binding protein that functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP-ribosyltransferase. Involved in protein trafficking among different compartments. Modulates vesicle budding and uncoating within the Golgi complex. Deactivation induces the redistribution of the entire Golgi complex to the endoplasmic reticulum, suggesting a crucial role in protein trafficking. In its GTP-bound form, its triggers the association with coat proteins with the Golgi membrane. The hydrolysis of ARF1-bound GTP, which is mediated by ARFGAPs proteins, is required for dissociation of coat proteins from Golgi membranes and vesicles. The GTP-bound form interacts with PICK1 to limit PICK1-mediated inhibition of Arp2/3 complex activity; the function is linked to AMPA receptor (AMPAR) trafficking, regulation of synaptic plasicity of excitatory synapses and spine shrinkage during long-term depression (LTD)..
Protein Sequence MGNIFANLFKGLFGKKEMRILMVGLDAAGKTTILYKLKLGEIVTTIPTIGFNVETVEYKNISFTVWDVGGQDKIRPLWRHYFQNTQGLIFVVDSNDRERVNEAREELMRMLAEDELRDAVLLVFANKQDLPNAMNAAEITDKLGLHSLRHRNWYIQATCATSGDGLYEGLDWLSNQLRNQK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2N-myristoyl glycine------MGNIFANLF
------CCCHHHHHH
35.62-
2Myristoylation------MGNIFANLF
------CCCHHHHHH
35.6223535599
2Acetylation------MGNIFANLF
------CCCHHHHHH
35.6219413330
22SulfoxidationKKEMRILMVGLDAAG
CCCEEEEEEEECCCC
1.7730846556
35PhosphorylationAGKTTILYKLKLGEI
CCCEEEEEEEECCCE
15.49-
36AcetylationGKTTILYKLKLGEIV
CCEEEEEEEECCCEE
35.3822647619
36UbiquitinationGKTTILYKLKLGEIV
CCEEEEEEEECCCEE
35.38-
38UbiquitinationTTILYKLKLGEIVTT
EEEEEEEECCCEEEE
50.7421906983
58PhosphorylationFNVETVEYKNISFTV
EEEEEEEEEEEEEEE
12.66-
62PhosphorylationTVEYKNISFTVWDVG
EEEEEEEEEEEEECC
25.0222199227
64PhosphorylationEYKNISFTVWDVGGQ
EEEEEEEEEEECCCC
17.5620068231
73SumoylationWDVGGQDKIRPLWRH
EECCCCCCCHHHHHH
32.50-
73UbiquitinationWDVGGQDKIRPLWRH
EECCCCCCCHHHHHH
32.5021906983
81PhosphorylationIRPLWRHYFQNTQGL
CHHHHHHHHCCCCEE
9.7829759185
85PhosphorylationWRHYFQNTQGLIFVV
HHHHHCCCCEEEEEE
17.1528152594
110SulfoxidationAREELMRMLAEDELR
HHHHHHHHHHHHHHH
2.3130846556
117MethylationMLAEDELRDAVLLVF
HHHHHHHHHHHHHHE
28.00-
127UbiquitinationVLLVFANKQDLPNAM
HHHHEECCCCCCCCC
41.5821906983
134SulfoxidationKQDLPNAMNAAEITD
CCCCCCCCCHHHHHH
4.4530846556
140PhosphorylationAMNAAEITDKLGLHS
CCCHHHHHHHHCCHH
20.7020860994
142AcetylationNAAEITDKLGLHSLR
CHHHHHHHHCCHHCC
35.4966698813
142UbiquitinationNAAEITDKLGLHSLR
CHHHHHHHHCCHHCC
35.4921906983
147PhosphorylationTDKLGLHSLRHRNWY
HHHHCCHHCCCCCEE
31.9423927012
167PhosphorylationATSGDGLYEGLDWLS
ECCCCCHHHHHHHHH
17.3020736484

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
-KUbiquitinationE3 ubiquitin ligaseFBH1Q8NFZ0
PMID:24658274

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
2GMyristoylation

19413330
3NMyristoylation

23535599

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ARF1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
GGA3_HUMANGGA3physical
10747089
ACM3_HUMANCHRM3physical
12799371
NOA1_HUMANNOA1physical
16169070
WBP11_HUMANWBP11physical
16169070
EF1G_HUMANEEF1Gphysical
16169070
COPB_HUMANCOPB1physical
10921873
COPE_HUMANCOPEphysical
10921873
ARFP1_HUMANARFIP1physical
9038142
ARFP2_HUMANARFIP2physical
9038142
GGA3_HUMANGGA3physical
11301005
ARF1_HUMANARF1physical
7990966
AP4M1_HUMANAP4M1physical
11707398
AP4E1_HUMANAP4E1physical
11707398
PLD1_HUMANPLD1physical
9688545
ERD21_HUMANKDELR1physical
11703931
GEA1_YEASTGEA1physical
14690595
NEF_HV1H2nefphysical
15202998
COPB_HUMANCOPB1physical
15202998
ARF3_HUMANARF3physical
22939629
T106A_HUMANTMEM106Aphysical
21988832
ACADM_HUMANACADMphysical
26344197
AHSA1_HUMANAHSA1physical
26344197
ARF4_HUMANARF4physical
26344197
ARF5_HUMANARF5physical
26344197
ARFG1_HUMANARFGAP1physical
26344197
ARFG2_HUMANARFGAP2physical
26344197
ARFG3_HUMANARFGAP3physical
26344197
TCPG_HUMANCCT3physical
26344197
TCPZ_HUMANCCT6Aphysical
26344197
EI2BA_HUMANEIF2B1physical
26344197
ETFA_HUMANETFAphysical
26344197
GALE_HUMANGALEphysical
26344197
GLRX5_HUMANGLRX5physical
26344197
LDHA_HUMANLDHAphysical
26344197
LDH6A_HUMANLDHAL6Aphysical
26344197
LDH6B_HUMANLDHAL6Bphysical
26344197
LDHB_HUMANLDHBphysical
26344197
LDHC_HUMANLDHCphysical
26344197
PUR6_HUMANPAICSphysical
26344197
PLD1_HUMANPLD1physical
26344197
KAPCB_HUMANPRKACBphysical
26344197
RB11A_HUMANRAB11Aphysical
26344197
RB11B_HUMANRAB11Bphysical
26344197
RAB1A_HUMANRAB1Aphysical
26344197
RAB1B_HUMANRAB1Bphysical
26344197
RAB2A_HUMANRAB2Aphysical
26344197
RAB5A_HUMANRAB5Aphysical
26344197
RAB6A_HUMANRAB6Aphysical
26344197
RAB6B_HUMANRAB6Bphysical
26344197
SAR1A_HUMANSAR1Aphysical
26344197
EFTU_HUMANTUFMphysical
26344197
SNUT2_HUMANUSP39physical
26344197
APRIO_HUMANPRNPphysical
25896910
PRIO_HUMANPRNPphysical
25896910
ASAP1_HUMANASAP1physical
16332543
AGAP1_HUMANAGAP1physical
16332543
ARFG1_HUMANARFGAP1physical
16332543
PAXI_HUMANPXNphysical
16332543
COPB_HUMANCOPB1physical
16332543

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ARF1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Myristoylation
ReferencePubMed
"Strategy for comprehensive identification of human N-myristoylatedproteins using an insect cell-free protein synthesis system.";
Suzuki T., Moriya K., Nagatoshi K., Ota Y., Ezure T., Ando E.,Tsunasawa S., Utsumi T.;
Proteomics 10:1780-1793(2010).
Cited for: MYRISTOYLATION AT GLY-2.
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-147, AND MASSSPECTROMETRY.

TOP